Back

Predictors of no-reflow phenomenon among patients with ST-Elevation myocardial infarction undergoing pharmacoinvasive strategy

4 March 2019 (09:00 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 3 - Acute Coronary Syndromes: Treatment, Revascularization Revascularisation ACVC Premium Access Acute Cardiovascular Care 2019

About the speaker

Photo
Doctor Rodrigo Gopar-Nieto

National Institute of Cardiology Ignacio Chavez, Mexico City (Mexico)

3 More presentations in this session

Presentation thumbnail
Doctor A. Gamal (Cairo, EG)
Abstract
Presentation thumbnail
Doctor F. Fortuni (Perugia, IT)
Abstract
Presentation thumbnail
Doctor F. Fortuni (Perugia, IT)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Acute Coronary Syndromes: Treatment, Revascularization

The Event

Event poster

Acute Cardiovascular Care 2019

4 March 2019 09:00 CET
You may be interested in
thumbnail
Congress Presentation
The specific characteristics and independent predictors of no-reflow phenomenon, development of a clinically-adaptable risk estimation system
31 August 2019
thumbnail
Congress Presentation
STEMI antiplatelet pretreatment strategy - national multicenter registry experience
9 March 2024
thumbnail
Congress Presentation
Heart Failure incidence following ST-elevation myocardial infarction: results from a contemporary cohort.
29 June 2021
thumbnail
Congress Presentation
Clinical factors associated with microvascular obstruction in early presenters of ST-segment elevation myocardial infarction
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources